CytomX Therapeutics (NASDAQ:CTMX) is set to give its latest quarterly earnings report on Monday, 2024-03-11. Here’s what investors need to know before the announcement.
Analysts estimate that CytomX Therapeutics will report an earnings per share (EPS) of $-0.03.
CytomX Therapeutics bulls will hope to hear the company announce they’ve not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the …